A Report from the 54th Annual Meeting of the European Society for Dermatological Research (ESDR).
The 2025 ESDR Congress in Antwerp brought together over 1,000 dermatology researchers. This report summarizes the…
The 2025 ESDR Congress in Antwerp brought together over 1,000 dermatology researchers. This report summarizes the…
View ReportWelcome the newest leadership to the IPC Board of Directors! Meet incoming IPC President Bruce Strober, Vice…
Read MoreThe 2024 IPC Think Tank Congress Report provides a comprehensive summary of key topics, including the epidemiology of…
Read MoreThe 33rd Annual EADV Congress in Amsterdam featured updates on psoriasis care, including highlights from the IPC…
Read MoreGeneralized pustular psoriasis(GPP)lacks internationally accepted definitions and diagnostic criteria, impeding timely…
View ReportRead key highlights from the 2023 International Psoriasis Council (IPC) Think Tank Meeting, summarizing the evolving…
Read MoreAccess the latest insights from the 32nd European Academy of Dermatology and Venereology 2023 Congress (EADV) in…
Read MoreIPC stands for accessible treatment and universal healthcare on World Psoriasis Day and beyond. Gain insights from…
Read MoreThe IPC Board of Directors is pleased to announce that it has named Hervé Bachelez, MD, PhD, as its newly appointed…
Read MoreThe European Academy of Dermatology and Venereology (EADV) organized its 31st congress in Milano, Italy, under the…
Read MoreEUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (EADV) | BERLIN, GERMANY Wednesday, October 11 8:30 – 11:45 am…
Experts worldwide report on their experiences and deliver insight into the latest results and clinical studies. The…
View ReportThe 7th Congress of the Skin Inflammation & Psoriasis International Network (SPIN) was held Wednesday, July 6 –…
Read MoreIPC's newly appointed appointed officers take their roles beginning January 1, 2022.
Read MoreThe European Academy of Dermatology and Venerelogy 30th Annual Congress (EADV) was packed with science and clinical…
Read MoreThomas Sharnitz, MD, has written the report, summarizing the most important presentations with a focus on psoriasis…
View ReportRecently, the Task Force (TF) of the National Psoriasis Foundation (NPF) released a revised version of its COVID-19…
Read MoreView Report
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
A new IPC paper in JAAD presents five priorities for improving metabolic screening, advancing GLP-1 research in the context of psoriasis, and defining the dermatologist’s role in managing cardiometabolic risk in psoriasis patients.
IPC Jr. Councilor Mio Nakamura speaks with Dr. John Koo about how personality traits, including borderline personality disorder, shape clinical interactions and shares practical strategies for dermatologists to build stronger patient relationships.
Recordings from the IPC Fellows Research Class #1: Global and Collaborative Research in Psoriasis are now available. Program Chairs Peter van de Kerkhof, MD, PhD, and María Julia Cura, MD, led a faculty of international experts through sessions on unresolved questions in the era of effective psoriasis therapies, building global research collaborations, and connecting psoriasis research across disciplines. Watch to hear from Wolf Henning Boehncke, MD, MA, Christopher Griffiths, OBE, MD, FMedSci, and Georg Stingl, MD, as they share perspectives shaping the next generation of psoriasis research.
The IPC Resource Library now includes a dedicated Research Skills category, bringing together videos, articles, and presentations focused on building stronger research capabilities in psoriasis. Browse the current collection to find resources on topics from collaborative research methods to career development for researchers at every stage.
Rare ADAR1 gene mutations drive a distinct, interferon-fueled psoriasis subtype, and it responds to JAK1 and TYK2 inhibitors rather than standard IL-17/IL-23 biologics.
IPC Councilor Anna Lopez Ferrer, MD, PhD, reviews PURE-4, a four-item tool that helps dermatologists screen psoriasis patients for psoriatic arthritis (PsA) risk. She traces its evolution across three studies (2018–2026) into a validated predictor of early PsA.
IPC Councilor André Lucas Ribeiro, MD, reframes PsA as a slow transition from psoriasis, not a sudden event, opening the door to disease interception. He outlines the steps needed to get there, from harmonizing definitions to reducing inflammatory burden.